Hardman & Co Research 2

Hardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM

Hardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns

Q&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends

Q&A on H&T Group (HAT): 2023 results – strong core growth

Hardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress

Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth